Clindamycin

Overview

Clindamycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1753).

API suppliers (20)

Suppliers of Clindamycin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Zhejiang Hisun Pharmaceutical Co., Ltd.China3 active DMF
• Yifan Pharmaceutical Co., Ltd.China2 active DMF
• Ono Pharmaceutical Co., Ltd.Japan2 active DMF
• CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina2 active DMF
• PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC1 active DMF
• TRIFARMA SPA1 active DMF
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
• PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC1 active DMF
• TRIFARMA SPA1 active DMF
• ALCHYMARS ICM SM PRIVATE LTD1 active DMF
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
• TRIFARMA SPA1 active DMF
• PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC1 active DMF
• UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
• ALCHYMARS ICM SM PRIVATE LTD1 active DMF
• ALCHYMARS ICM SM PRIVATE LTD1 active DMF
• ALCHYMARS ICM SM PRIVATE LTD1 active DMF
• SUZHOU NUMBER 4 PHARMACEUTICAL FACTORY
• HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina
• Aurobindo Pharma LimitedIndia

Patent & exclusivity (US)

Per the FDA Orange Book (77 approved US products), the latest listed US patent on Clindamycin expires 21 Sept 2036 and exclusivity 7 Dec 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide

Canonical SMILES

CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl

InChIKey

KDLRVYVGXIQJDK-AWPVFWJPSA-N